FindTrial
Sign In

Effect of active screening of carbapenem-resistant gram-negative bacilli on prognosis of critically ill patients

Effect of active screening of carbapenem-resistant gram-negative bacilli on prognosis of critically ill patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048501
Enrollment
Unknown
Registered
2021-07-09
Start date
2021-07-09
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious diseases caused by drug-resistant bacteria

Interventions

Gold Standard:Clinical symptoms, imaging findings, etiological results
Index test:CRE&#32
screening,&#32
drug&#32
resistance&#32
gene&#32
testing

Sponsors

Wuhan University, Zhongnan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients transferred to a long-term care facility; 2.Transferred patients from other hospitals; 3.Critical patients transferred from general wards for more than 3 days in hospital; 4.Newly admitted patients with a history of hospitalization in the last 6 months; 5.Antibiotic exposure in the last 6 months; 6.Patients with related dysfunction (especially fecal incontinence); 7.Transplant/long-term immunosuppressant/chemotherapy patients.

Exclusion criteria

Exclusion criteria: 1.Pregnant woman; 2.Age<18 years of age.

Design outcomes

Primary

MeasureTime frame
drug resistance gene;—

Countries

China

Contacts

Public ContactPeng Zhiyong

Wuhan University, Zhongnan Hospital

pengzy5@hotmail.com+86 18672396028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026